Ftse Mib
34.502,72
-0,45%
DAX
18.605,49
-0,42%
S&P 500
5.306,04
0,02%
NASDAQ
17.019,88
0,59%
Bitcoin
67.835,39
-0,67%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TFF Pharmaceuticals Inc (TFFP) TFF Pharmaceuticals Inc (TFFP) Notizie

TFFP

TFF Pharmaceuticals (TFFP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TFFP
DataOraFonteTitoloSimboloCompagnia
17/05/202422:07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
17/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
14/05/202422:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
07/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
08/12/202322:52Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202323:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202323:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
21/11/202322:41Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322:10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322:07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322:07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TFFPTFF Pharmaceuticals Inc
22/09/202322:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
17/08/202322:01GlobeNewswire Inc.TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionNASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202312:00GlobeNewswire Inc.TFF Pharmaceuticals Prices $5 Million Public Offering of Common StockNASDAQ:TFFPTFF Pharmaceuticals Inc
27/06/202312:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TFFPTFF Pharmaceuticals Inc
23/06/202323:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TFFPTFF Pharmaceuticals Inc
11/05/202322:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/03/202321:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/02/202322:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TFFPTFF Pharmaceuticals Inc
27/12/202215:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
15/12/202223:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
17/11/202212:35TipRanksTFF Pharmaceuticals (TFFP) Receives a Buy from H.C. WainwrightNASDAQ:TFFPTFF Pharmaceuticals Inc
04/11/202220:35TipRanksMaxim Group Keeps Their Buy Rating on TFF Pharmaceuticals (TFFP)NASDAQ:TFFPTFF Pharmaceuticals Inc
02/11/202214:17TipRanksTFF Pharma Tanks After Delay in the Release of Clinical DataNASDAQ:TFFPTFF Pharmaceuticals Inc
26/10/202215:15TipRanksMaxim Group Remains a Buy on TFF Pharmaceuticals (TFFP)NASDAQ:TFFPTFF Pharmaceuticals Inc
06/10/202223:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
16/08/202217:15TipRanksTFF Pharmaceuticals (TFFP) Gets a Buy from Maxim GroupNASDAQ:TFFPTFF Pharmaceuticals Inc
16/08/202212:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on TFF Pharmaceuticals (TFFP)NASDAQ:TFFPTFF Pharmaceuticals Inc
19/05/202214:20TipRanksAnalysts Offer Insights on Healthcare Companies: Pfizer (PFE) and TFF Pharmaceuticals (TFFP)NASDAQ:TFFPTFF Pharmaceuticals Inc
06/04/202203:09TipRanks2 Stocks Under $10 That This Insider Is Aggressively BuyingNASDAQ:TFFPTFF Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TFFP

La tua Cronologia

KUCN
SFPUSDT
SafePal Token
AQSE
CNG.GB
China Nonferrous Gold
BIT
P20C16
NLBNPIT20C16 20240621 105
BIT
P1NHL6
BNP Paribas Issuance
BIT
P1RWO0
BNP Paribas Issuance
BIT
P110P0
Bnp Paribas Issuance
EU
UNECI
UNEDIC 0.1% until 25nov2...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network